How to manage CVD risk in PCa patients during COVID-19

Prof. P-A. Abrahamsson (SE)
Prof. P-A. Abrahamsson (SE)
Prof. A.K. Ghosh (GB)
Prof. M. Linch (GB)
Dr. R.A. Rendon (CA)
Prof. Dr. M.J. Ribal Caparros (ES)
Date & time
Wednesday, 7 April 2021, 18:30 - 19:30 CEST

How do you manage CVD risk in PCa patients during COVID-19?
What's in store for you in Module 2?

Look forward to the following presentations by renowned experts in their respective fields:

Moderator: P-A. Abrahamsson (SE)

Impact of COVID-19 on cardio-oncology
By Prof. Arjun Ghosh (GB), cardio-oncologist

COVID-19 Recommendations for Prostate Cancer treatment by the EAU Guidelines
By Prof. Dr. Maria Ribal (ES), urologist

How to manage prostate cancer in a pandemic
By Dr. Ricardo Rendon (CA), urologic oncologist

Hormonal treatment of urological cancers during COVID-19
By Prof. Mark Linch (GB), oncologist 

This online curriculum is developed by the Canadian Urological Association (CUA), the International Cardio-Oncology Society (ICOS), and the European Association of Urology (EAU) and combines quality scientific content with current evidence-based recommendations and real-life clinical practice experience. 

At a glance
Publication date: April 2021
Available languages: English
Topic: Prostate cancer
CME: This webinar is accredited with 1 European CME credit (ECMEC®) upon completion of the questionnaire after attending the live webinar
Duration: Approx. 60 minutes

This educational activity has been funded by Ferring. The educational programme of this online activity has been a collaboration with Ferring, but independently developed and approved by the Canadian Urological Association, the International Cardio-Oncology Society together with the European Association of Urology.

Registration for this webinar is now closed

The recording will be available at 24 hours after the webinar has taken place.

Back to UROwebinar overview
Contact information
European Association of Urology
Registration Department
+31 (0)26 389 1751